Form D · Biotechnology
Theraclion
Malakoff, I0 · CIK 0001646900
Offering snapshot reported Jul 1, 2015 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 19, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 1, 2015 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $12.5K
- Finders' fees
- $0
- Form D file number
- 021-242930
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LifeSci Capital LLC | 168404 |
Source: Form D, filed Jul 1, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarah Ankri | Executive |
| Jean Yves Burel | Director |
| David Caumartin | Executive |
| Vincent Gardes | Director |
| Anja Kleber | Executive |
| Francois La Coste | Director |
| Laurent Levy | Director |
| Michel Nuta | Executive |
| Phillippe Pouletty | Director |
| Bern Von Polheim | Director |
| Sylvain Yon | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
102, Rue Etienne Dolet
Malakoff, I0, 92240
Malakoff, I0, 92240